Find a Clinical Trial

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by trial titles, indicators and specific disease types.

Lymphomas

Clinical Trial at: Arizona Oncology - Phoenix

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Lung Cancer

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, AZ 85027
P: (602) 357-2400

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Phoenix

A RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AVELUMAB (MSB0010718C) IN COMBINATION WITH AND/OR FOLLOWING CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED EPITHELIAL OVARIAN CANCER (B9991010)

  • Details

ClinicalTrials.gov ID: NCT02718417
Diagnosis Type: NA
USOR Number: 16080

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Cervical Cancer

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Neuroendocrine Tumors

Clinical Trial at: Arizona Oncology - Phoenix

A Phase 3, Prospective, Randomized, Double-Blind, Multi-Center, Study of the Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg plus BSC vs. Placebo plus BSC for Tumour Control in Subjects with Well Differentiated, Metastatic and/or Unresectable Typical or Atypical Lung Neuroendocrine Tumours (Spinet) - Ipsen A-US-52030-328

  • Details

ClinicalTrials.gov ID: NCT02683941
Diagnosis Type: NA
USOR Number: 15079

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, AZ 85027
P: (602) 357-2400

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Phoenix

A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY OF PF-05280586 VERSUS RITUXIMAB FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH CD20-POSITIVE, LOW TUMOR BURDEN, FOLLICULAR LYMPHOMA - Pfizer B3281006

  • Details

ClinicalTrials.gov ID: NCT02213263
Diagnosis Type: Non-Hodgkins
USOR Number: 14020

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Cervical Cancer

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, AZ 85027
P: (602) 357-2400

More Details View Practice Page

Leukemia

Clinical Trial at: Arizona Oncology - Phoenix

A Phase 2 Study of the Efficacy and Safety of ACP-196 in Subjects with Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy (ACE-CL-208)

  • Details

ClinicalTrials.gov ID: NCT02717611
Diagnosis Type: NA
USOR Number: 15222

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, AZ 85027
P: (602) 357-2400

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Phoenix

A RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AVELUMAB (MSB0010718C) IN COMBINATION WITH AND/OR FOLLOWING CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED EPITHELIAL OVARIAN CANCER (B9991010)

  • Details

ClinicalTrials.gov ID: NCT02718417
Diagnosis Type: NA
USOR Number: 16080

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, AZ 85027
P: (602) 357-2400

More Details View Practice Page

Colon Cancer

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Esophageal Cancer

Clinical Trial at: Arizona Oncology - Phoenix

A Phase III Randomized Open-label Study of Single Agent Pembrolizumab vs Physicians' Choice of Single Agent Docetaxel, Paclitaxel, or Irinotecan in Subjects with Advanced/Metastatic Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus that have Progressed after First-Line Standard Therapy (KEYNOTE-181)

  • Details

ClinicalTrials.gov ID: NCT02564263
Diagnosis Type: NA
USOR Number: 15133

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Lung Cancer

Clinical Trial at: Arizona Oncology - Phoenix

CA209370: A Master Protocol of Phase 1/2 Studies of Nivolumab in Advanced NSCLC Using Nivolumab as Maintenance after Induction Chemotherapy or as First-line Treatment Alone or in Combination with Standard of Care Therapies

  • Details

ClinicalTrials.gov ID: NCT02574078
Diagnosis Type: NSCLC
USOR Number: 14158

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Colon Cancer

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, AZ 85027
P: (602) 357-2400

More Details View Practice Page

Leukemia

Clinical Trial at: Arizona Oncology - Phoenix

A Phase 2 Study of the Efficacy and Safety of ACP-196 in Subjects with Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy (ACE-CL-208)

  • Details

ClinicalTrials.gov ID: NCT02717611
Diagnosis Type: NA
USOR Number: 15222

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, AZ 85027
P: (602) 357-2400

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, AZ 85027
P: (602) 357-2400

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Phoenix

FOCUS: A Multicenter, Multinational, Double-Blind, 2-Arm, Randomized, Phase 2/3, Study of Physician’s Choice Chemotherapy ([PCC] Weekly Paclitaxel or Pegylated Liposomal Doxorubicin [PLD]) Plus Bevacizumab and CA4P Versus PCC Plus Bevacizumab and Placebo for Subjects with Platinum-Resistant, Recurrent Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer (OX4325)

  • Details

ClinicalTrials.gov ID: NCT02641639
Diagnosis Type: NA
USOR Number: 16081

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Pages